Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 7.21% on an annualized basis.
Buying $100 In VRTX: 10 years ago, an investor could have purchased 3.10 shares of Vertex Pharmaceuticals at the time with $100. This investment in VRTX would have produced an average annual return of 21.31%. Currently, Vertex Pharmaceuticals has a market capitalization of $56.43 billion.
Vertex Pharmaceuticals's Share Price Over Last 10 Years
If you had invested $100 in Vertex Pharmaceuticals you would have approximately $690.35 today.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
You can check out Benzinga's market data in an enhanced view on Benzinga Pro
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.